XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.3
CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY - USD ($)
shares in Thousands, $ in Thousands
Common Stock
Retained Earnings
Treasury Stock
Accumulated Other Comprehensive Loss
Total
Balance at Dec. 31, 2021 $ 722,310 $ 2,163,916 $ (618,712)   $ 2,267,514
Balance (in shares) at Dec. 31, 2021 82,336   (31,956)    
Increase (Decrease) in Stockholders' Equity          
Net Income (loss)   17,734     17,734
Exercise of common stock options and vested employee stock awards $ 27       27
Exercise of common stock options and vested employee stock awards (in shares) 139        
Employee income tax paid on vested equity awards     $ (1,123)   (1,123)
Employee income tax paid on vested equity awards (in shares)     (37)    
Sale of common stock under employee stock purchase plan $ 1,487       1,487
Sale of common stock under employee stock purchase plan (in shares) 40        
Stock based compensation expense $ 4,076       4,076
Balance at Mar. 31, 2022 $ 727,900 2,181,650 $ (619,835)   2,289,715
Balance (in shares) at Mar. 31, 2022 82,515   (31,993)    
Balance at Dec. 31, 2021 $ 722,310 2,163,916 $ (618,712)   2,267,514
Balance (in shares) at Dec. 31, 2021 82,336   (31,956)    
Increase (Decrease) in Stockholders' Equity          
Net Income (loss)         120,057
Net unrealized appreciation (depreciation) on marketable securities, net of tax         (4,569)
Balance at Sep. 30, 2022 $ 736,406 2,283,973 $ (619,862) $ (4,569) 2,395,948
Balance (in shares) at Sep. 30, 2022 82,592   (31,994)    
Balance at Mar. 31, 2022 $ 727,900 2,181,650 $ (619,835)   2,289,715
Balance (in shares) at Mar. 31, 2022 82,515   (31,993)    
Increase (Decrease) in Stockholders' Equity          
Net Income (loss)   53,951     53,951
Stock based compensation expense $ 3,310       3,310
Net unrealized appreciation (depreciation) on marketable securities, net of tax       (1,945) (1,945)
Balance at Jun. 30, 2022 $ 731,210 2,235,601 $ (619,835) (1,945) 2,345,031
Balance (in shares) at Jun. 30, 2022 82,515   (31,993)    
Increase (Decrease) in Stockholders' Equity          
Net Income (loss)   48,372     48,372
Exercise of common stock options and vested employee stock awards $ 115       115
Exercise of common stock options and vested employee stock awards (in shares) 11        
Employee income tax paid on vested equity awards     $ (27)   (27)
Employee income tax paid on vested equity awards (in shares)     (1)    
Sale of common stock under employee stock purchase plan $ 1,329       1,329
Sale of common stock under employee stock purchase plan (in shares) 66        
Stock based compensation expense $ 3,752       3,752
Net unrealized appreciation (depreciation) on marketable securities, net of tax       (2,624) (2,624)
Balance at Sep. 30, 2022 $ 736,406 2,283,973 $ (619,862) (4,569) 2,395,948
Balance (in shares) at Sep. 30, 2022 82,592   (31,994)    
Balance at Dec. 31, 2022 $ 734,426 2,236,869 $ (619,862) (3,802) 2,347,631
Balance (in shares) at Dec. 31, 2022 82,593   (31,994)    
Increase (Decrease) in Stockholders' Equity          
Net Income (loss)   (22,071)     (22,071)
Exercise of common stock options and vested employee stock awards $ 57       57
Exercise of common stock options and vested employee stock awards (in shares) 130        
Employee income tax paid on vested equity awards     $ (585)   (585)
Employee income tax paid on vested equity awards (in shares)     (32)    
Sale of common stock under employee stock purchase plan $ 1,218       1,218
Sale of common stock under employee stock purchase plan (in shares) 78        
Stock based compensation expense $ 4,329       4,329
Treasury stock purchases     $ (100,001)   (100,001)
Treasury stock purchases (in shares)     (5,067)    
Net unrealized appreciation (depreciation) on marketable securities, net of tax       1,480 1,480
Balance at Mar. 31, 2023 $ 740,030 2,214,798 $ (720,448) (2,322) 2,232,058
Balance (in shares) at Mar. 31, 2023 82,801   (37,093)    
Balance at Dec. 31, 2022 $ 734,426 2,236,869 $ (619,862) (3,802) 2,347,631
Balance (in shares) at Dec. 31, 2022 82,593   (31,994)    
Increase (Decrease) in Stockholders' Equity          
Net Income (loss)         16,826
Net unrealized appreciation (depreciation) on marketable securities, net of tax         3,618
Balance at Sep. 30, 2023 $ 750,133 2,253,695 $ (866,946) (184) 2,136,698
Balance (in shares) at Sep. 30, 2023 82,840   (41,620)    
Balance at Mar. 31, 2023 $ 740,030 2,214,798 $ (720,448) (2,322) 2,232,058
Balance (in shares) at Mar. 31, 2023 82,801   (37,093)    
Increase (Decrease) in Stockholders' Equity          
Net Income (loss)   15,419     15,419
Stock based compensation expense $ 4,246       4,246
Treasury stock purchases     $ (95,998)   (95,998)
Treasury stock purchases (in shares)     (3,335)    
Net unrealized appreciation (depreciation) on marketable securities, net of tax       1,514 1,514
Balance at Jun. 30, 2023 $ 744,276 2,230,217 $ (816,446) (808) 2,157,239
Balance (in shares) at Jun. 30, 2023 82,801   (40,428)    
Increase (Decrease) in Stockholders' Equity          
Net Income (loss)   23,478     23,478
Sale of common stock under employee stock purchase plan $ 1,536       1,536
Sale of common stock under employee stock purchase plan (in shares) 39        
Stock based compensation expense $ 4,321       4,321
Treasury stock purchases     $ (50,500)   (50,500)
Treasury stock purchases (in shares)     (1,192)    
Net unrealized appreciation (depreciation) on marketable securities, net of tax       624 624
Balance at Sep. 30, 2023 $ 750,133 $ 2,253,695 $ (866,946) $ (184) $ 2,136,698
Balance (in shares) at Sep. 30, 2023 82,840   (41,620)